Biarritz Meeting. 12th International Congress



Similar documents
TUESDAY OCTOBER, 11st WEDNESDAY OCTOBER, 12ND

11th International Congress

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

Outline. Drug and Alcohol Counseling 1 Module 1 Basics of Abuse & Addiction

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

HEROIN AND RELATED OPIATES

Clinical Priorities for Alcohol and Drugs in Public Health

Scientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances

Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance

Objectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons.

EPIDEMIOLOGY OF OPIATE USE

Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center

Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community

opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top

How To Treat An Addict

Treatment Approaches for Drug Addiction

Title: The Certified Medication Assisted Treatment Advocate (CMA) Training Course

MORTALITY AMONGST ILLICIT DRUG USERS

Treatment Approaches for Drug Addiction

Medication-Assisted Addiction Treatment

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

Rekindling House Dual Diagnosis Specialist

Alcohol and Drug. A Cochrane Handbook. losief Abraha MD. Cristina Cusi MD. Regional Health Perugia

SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio

Treatment of opioid use disorders

DrugFacts: Treatment Approaches for Drug Addiction

EPIDEMIC 4.6 % OF INDIVIDUALS USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

OVERVIEW WHAT IS POLyDRUG USE? Different examples of polydrug use

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania

Title: Opening Plenary Session Challenges and Opportunities to Impact the Opioid Dependence Crisis

Addiction Psychiatry Fellowship Rotation Goals & Objectives

Treatment Approaches for Drug Addiction

Assessment and Diagnosis of DSM-5 Substance-Related Disorders

Alcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem. Thomas Kosten MD

John R. Kasich, Governor Orman Hall, Director

Testimony of The New York City Department of Health and Mental Hygiene. before the

SROM (oral morphine) an add on medication for the treatment of opioid dependence: risks & benefits. Gabriele Fischer. Medical University Vienna

The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction

THE DRUG DETOX UNIT AT MOUNTJOY PRISON A REVIEW

TREATMENT MODALITIES. May, 2013

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011

Frequently asked questions

Use of Vivitrol for Alcohol and Opioid Addiction

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY TENTH WAVE WORK PROGRAMME DRUG MISUSE. Psychosocial interventions in drug misuse

Department of Psychiatry & Health Behavior. Medical Student Electives in Psychiatry

Opioid overdose can occur when a patient misunderstands the directions

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

Wednesday, March 7 th Genealogy and actuality of research. 9 : 00 am Opening Remarks (by Officials)

Heroin Overdose Trends and Treatment Options. Neil A. Capretto, D.O., F.A.S.A.M. Medical Director

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.

INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Settima scuola estiva di Neuroscienze (7)

Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead SMMGP

Co-Occurring Substance Use and Mental Health Disorders. Joy Chudzynski, PsyD UCLA Integrated Substance Abuse Programs

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

CLINICAL POLICY Department: Medical Management Document Name: Vivitrol Reference Number: NH.PHAR.96 Effective Date: 03/12

DEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd

DEPARTMENT OF PSYCHIATRY Centre Street Boston, MA 02130

Allyse Adams PC, LICDC Oriana House, Inc.

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions

Using Drugs to Treat Drug Addiction How it works and why it makes sense

Co-morbid Mental Illness & Substance Abuse Challenges to Treatment

Croydon Drug and Alcohol Services. Directory of drug and alcohol services available in Croydon

Do we need special programs for aging drug users?

WEST LOTHIAN ADDICTION SERVICES DIRECTORY INFORMATION

INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Sesta scuola estiva di Neuroscienze (7)

Dual diagnosis: working together

Addiction Pharmacotherapies in Integrated Systems OPIOIDS

How To Treat A Mental Illness At Riveredge Hospital

Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay.

Drugs and Addiction Policy in the Federal Republic of Germany

Drug Abuse and Addiction

Treatment Programs (OMTP)

Substance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates

Understanding Addiction: The Intersection of Biology and Psychology

Beyond SBIRT: Integrating Addiction Medicine into Primary Care

Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry

Opioid Addiction & Corrections

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery

Opioid/Opiate Dependent Pregnant Women

Course Description. SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES

drug treatment in england: the road to recovery

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK

University of the State of New York; New York State Licensed Psychologist Since 1983; #7640.

UNODC World Drug Report 2016:

Suboxone Programs: Treating Opioid Dependence in CHCs Andrew Putney, MD Medical Director SSTAR ATS and CHC, Fall River, Massachusetts

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

Co-occurring Disorder Treatment for Substance Abuse and Compulsive Gambling

Transcription:

Biarritz Meeting 12th International Congress Addictions - Hepatitis - AIDS - (ATHS) Program September 29 - October 2nd, 2015 Bellevue Center of Congress - Biarritz plenary sessions, debates, workshops, posters twitter.com/thsbiarritz facebook.com/aths.biarritz www.aths-biarritz.com

Tuesday september 29 th 2015 05.00-05.30 pm : Under the High Patronage of Opening In the presence of Solange MENIVAL, vice President of the Regional counsil of Aquitaine, of Michel LAFORCADE, Directeur général de l Agence Régionale de Santé Aquitaine, and of Michel VEUNAC, Mayor of Biarritz 05.30-07.00 pm : simultaneously translated Conference/Debate : Hepatitis C, DAAs and public health : treating, who and when, and at what price? Victor de LEDINGHEN (Bordeaux), Christian TREPO (Lyon), Pascal MELIN (SOS Hépatites Saint Dizier), Jean-François CORTY (Médecins du Monde Paris), Daniel DHUMEAUX (Paris), Eberhard SCHATZ (Amsterdam) As a tribute to : Alain ROUSSET Président de la Région Aquitaine Jean-Jacques LASSERRE Président du Conseil Général des Pyrénées-Atlantiques Michel VEUNAC Maire de Biarritz Michel LAFORCADE Directeur général de l Agence Régionale de Santé Aquitaine Under the Honorary Presidency of Pr Françoise BARRE-SINOUSSI (Paris) Under the Presidency of Charles O BRIEN (Philadelphie) Christian TREPO (Lyon) Under the Direction of Jean-Pierre DAULOUEDE (Bayonne) General Secretory, Director of the Congress Arkaitz AGUERRETXE COLINA (Bayonne) Assistant General Secretory, Assistant Director of the Congress Marc AURIACOMBE (Bordeaux) Chairman of the scientific Comitee In collaboration with Jean-Marie Guffens Jean-Jacques DEGLON (Genève) President of the SETHS Pierre Pradier N enregistrement organisme : 2132 Développement professionnel continu : Association Nationale des Généralistes pour la Recherche et l Étude sur les Hépatopathies Chroniques graphisme : delfineandre@hotmail.com Partnerships :

Wednesday september 30 th 2015 08.30-10.15 am : Auditorium 1 - simultaneously translated Addictions Co-chair : Jean-Jacques DEGLON (Genève), Charles O BRIEN (Philadelphie) Moderation : Marc AURIACOMBE (Bordeaux) Addiction and gene-environment interaction / Mickaël NAASSILA (Amiens) Gene Variants Recently Identified as Associated with Opioid Addictions / Mary Jeanne KREEK (New York) Methadone and buprenorphine, safety issues / Adrian DUNLOP (Sidney) Addictions and sleep / Maurice DEMATTEIS (Grenoble) 10.30 am - 12.15 pm : Auditorium - simultaneously translated 10.15-10.30 am : break Brain substrates of relapse vulnerability : imaging the brain during cue - induced drug motivation («GO!») Anna Rose CHILDRESS (Philadephie) New therapeutics in addiction treatment / Ivan MONTOYA (Bethesda) Patient quality of life : for better and not for worse / Patrick MARTIN (Paris) Violence against women with subtsance abuse / Gabriele FISCHER (Vienne) 12.15-01.15 pm : Auditorium - simultaneously translated Indivior Symposium : Opioid analgesics addiction in patients experiencing pain Moderation : Marc AURIACOMBE (Bordeaux) Current state and screening / Serge PERROT (Paris) Identifying the different profiles of opioid analgesic misuses / Nicolas AUTHIER (Clermont-Ferrand) Management of opioid analgesic dependence : which place for substitution therapy? / Maurice DEMATTEIS (Grenoble) 02.30-04.30 pm : Auditorium - simultaneously translated Dual disorders Co-chair : Mehdi PAES (Rabat), Miguel CASAS (Barcelone) Moderation : Amine BENYAMINA (Paris) ADHD in opiate addicted patients : assessment and clinical features Constanza DAIGRE (Barcelone) Suicidal risk in gamblers asking for care Morgane GUILLOU LANDREAT (Nantes) Towards a specific psychopathology of heroin addiction Icro MAREMMANI (Pise) Gender influence and Dual Diagnosis in opiate-dependent patients / Carlos RONCERO (Barcelone) Rhune 1 - simultaneously translated Injectables opioids Co-chair : Nicolas AUTHIER (Clermont-Ferrand), Ambros UCHTENHAGEN (Zurich) Moderation : Miguel VELAZQUEZ (Paris) The function and role of heroin assisted treatment at the treatment system level / Ambros UCHTENHAGEN (Zurich) Morphine sulfate : «replacement or pleasure : do we have to choose»? Contradictory debate Nicolas AUTHIER (Clermont-Ferrand), Miguel VELAZQUEZ (Paris) Injectable buprenorphine : what are users s expectations? Perrine ROUX (Marseille) Naloxone, an antagonist to prevent and treat overdoses Jean-Michel DELILE (Bordeaux) 01.15-02.30 pm : lunch break, poster session 04.30-05.00 pm : break 02.30-03.30 pm : Rhune 2 Abbvie Symposium : Care of Chronic HCV drug users in prisons and addiction clinics From clinical practice to patient experience Fadi MEROUEH (Villeneuve-lès-Maguelonne) 02.30-04.30 pm : Vagues 3+4 Workshop 1 : An alternative to drug consumption rooms Chair : Serge LONGERE (Paris) Yann GRANGER (Marseille), Pascal PEREZ (Montreuil) Diane LESBOUEYRIES (Montreuil), David MICHELS (Paris) Vagues 1+2 Workshop 2 : Innovative clinical experiences in hepatology Co-chair : Véronique LATOUR (Bordeaux), Jean-Philippe LANG (Strasbourg) Chronic HCV : what are the new missions for psychiatrists and addiction specialists? / Jean-Philippe LANG (Strasbourg) Creation of a pedagogic tool based on an hepatitis talking group Fadila DEHAS (Montpellier), Caroline ALARCOS (Montpellier) Delivery of HCV treatment in harm reductions centers Véronique LATOUR (Bordeaux) Dynamics of viral C infection in drugs users in addiction clinics / Clotilde DUBURQUE (Lille) Does social vulnerability take part in HBV, HCV and HIV screening and access to HBV vaccination in IVDU in addiction clinics? / Fiorant DI-NINO (Strasbourg)

Wednesday september 30 th 2015/ following Auditorium - simultaneously translated Cannabinoids : research, clinics and use Co-chair : Amine BENYAMINA (Paris), Michel REYNAUD (Paris) Cannabis : Ethics and the Law Wim VAN DEN BRINK (Amsterdam) Cannabis Social Clubs Joan COLOM (Barcelone) Impact of regular cannabis use on the brain : interest of visual markers Vincent LAPREVOTE (Nancy) Rhune 1 - simultaneously translated Innovations in harm reduction in France Chair : Jean-François CORTY (Médecins du Monde Paris) Individual support and education on the harms associated with injection : place of common knowledge and issues of community research Marie JAUFFRET-ROUSTIDE (Paris) Take home naloxone : an action of common sense Jean-Pierre LHOMME (Paris) Rapid Diagnostic tests : a complementary tool close to exposed populations Marie-Dominique PAUTI (Paris) Patent opposition, acting for a real universal access to HCV treatment Olivier MAGUET (Paris) 07.15-08.15 pm : The «Fabrique du funambule» presents : 911 and a bit more... A lecture and then, characters to meet, to discover and not to let go... Keep the line available, this is an emergency call. Textes and acting : Twins (small) Towers Artistic conception : Little Man, Businessman, Cosmic girl 05.00-07.00 pm : Rhune 2 Workshop 1 : Harm reduction in tobacco use Moderation : Anne BORGNE (Paris) Electronic cigarette - legislation, politics, science : were do we stand? / Brice LEPOUTRE (Paris) Electronic cigarette in harm reduction centers Agnès LABORDE (Montreuil) Electronic cigarette use in Korsakoff patients Philippe MICHAUD (Villeneuve-la-Garenne) Vagues 1+2 Workshop 2 : Prisons Moderation : Saadia YAKOUB (Paris), Fadi MEROUEH (Villeneuve-lès-Maguelonne) First results of a sociological research on practices and perceptions of harm reduction in carceral environment Marie JAUFFRET ROUSTIDE (Paris) Availability and accessibility of harm reduction tools in prisons of 5 europeans states (data from the Pride Europe Study) : implications in public health Laurent MICHEL (Paris) Inmates rights and HIV infection Mohamed SOUMAH (Dakar) Out of prison unit : towards a continuity of cares in and out Véronique LATOUR (Bordeaux) HCV : knowledge, false beliefs and risky behavior in exprisoners and canadian control group Evelyne VALLIERES (Québec) How to improve internal communications in european prisons : Rehab project Fabio STERNBERG (Madrid) Vagues 3+4 Workshop 3 : Innovative clinical experiences in addictology Moderation : Eliane HERRAN (Bayonne) Relevance of motivational interviewing associated technics in adolescent cannabis users Jacques BERGERON (Montréal) Alcohol Marketing and alcohol use disorders Morgane GUILLOU (Nantes) Assessment of a cocaine and psychostimulants abstinence program in an addiction hospital Etienne POT (Lyon) Abuse of anabolic steroids in athletes : a bibliometric analysis / Victor AGULLO (Valencia) Learn in group how to channel one s anger Jean-Marie ROSSIER (Genève) Sexual addictions : therapeutic strategies to readjust a compulsive sexuality / Marthylle LAGADEC (Paris)

Thursday october 1 st 2015 08.45-11.45 am : Auditorium - simultaneously translated 08.45-09.30 am : Rhune 1 Drug use and infectious risks : HIV - HCV co infections HIV/HCV Lecture : Addiction to death / Marc REISINGER (Bruxelles) Co-chair : Jacques NORMAND (Bethesda), Christian TREPO (Lyon), Jean-François DELFRAISSY (Paris) Injection Drug Users and HIV : not Time to Declare Victory Jacques NORMAND (Bethesda) Reducing HIV incidence among people who inject drugs (PWID) in Ukraine : results from a peer-based network intervention / Robert BOOTH (Denver) Hepatitis C treatments : four aces game Christian TREPO (Lyon) Simplified diagnostics - the key to success Tanya APPLEGATE (Sidney) Interest of Ag Core quantification in HCV for the screening of chronic hepatitis C Karine LACOMBE (Paris) / Léa DUCHESNE (Paris) Challenges to Implement Integrated HCV Prevention Services / Jason FARRELL (Amsterdam) Eradicate coinfections Pascal MELIN (Saint Dizier) 09.45-11.45 am : Rhune 1 - simultaneously translated Opioids : new paths Co-chair : Mary Jeanne KREEK (New York), Charles O BRIEN (Philadelphie) Moderation : Marc REISINGER (Bruxelles) Psychiatric comorbidities in opioid-dependent patients : the influence on methdone doses Carlos RONCERO (Barcelone) Current status of Mu Opioid Receptor Directed Treatments for Opioid Addiction and a New Target for Novel Treatments of Cocaine Addiction and Adjunctive Treatment of Other Addictions Mary Jeanne KREEK (New York) SROM (slow release oral morphine) - an add-on medication for opioid dependence : risks & benefits Gabriele FISCHER (Vienne) A new method for relapse prevention in opiate addiction : slow release naltrexone Charles O BRIEN (Philadelphie) 11.45 am - 12.00 pm : break 12.00-01.30 pm : Auditorium - simultaneously translated Gilead Symposium : Multidisciplinary care : a key for HCV treatment in DU Moderation : Elisabeth AVRIL (Paris), Frédéric CHAFFRAIX (Strasbourg) Introduction : Presentations and discussions of multidisciplinary collaborations in the patient care pathway / Frédéric CHAFFRAIX (Strasbourg) Experience of Strasbourg s microstructures / Jean-Philippe LANG (Strasbourg) CSAPASCAN experience / Brigitte REILLER (Bordeaux) Mobile team in Perpignan / André-Jean REMY (Perpignan) Conclusion / Elisabeth AVRIL (Paris) 01.30-02h30 pm : lunch break, poster session ATHS 2013

Thursday october 2 nd 2015 / following Auditorium - simultaneously translated Alcohol, today and tomorrow Chair : Amine BENYAMINA (Paris) French and european recommandations Karl MANN (Mannheim) Focus on treatments Benjamin ROLLAND (Lille) Focus on alcohol research Nicolas SIMON (Marseille) Binge drinking un adolescence : cerebral consequences and addiction vulnerability, results from the european Alcobinge project / Mickael NAASSILA (Amiens) Rhune 1 - simultaneously translated Should Food/Eating Addiction replace current Eating Disorders? Chair : Charles O BRIEN (Philadelphie) Moderation : Marc AURIACOMBE (Bordeaux) Mélina FATSEAS (Bordeaux), Anna Rose CHILDRESS (Philadelphie) Charlotte KERVAN (Bordeaux), Julie COLLOMBAT (Bordeaux) 02.30-04.30 pm : 04.30-05.00 pm : break Vagues 3+4 Workshop 1 : Place of firstline stakeholders in addictology : general practitioners, pharmacists, work medicine : from early screening to long term follow up Moderation : Xavier AKNINE (Bondy) Pharmaddict : Place of the pharmacist Stéphane ROBINET (Paris) Clinical presentations on the role of GP Françoise ETCHEBAR (Pau), Bruno JOURNE (Paris) Presentation of the website «Intervenir Addictions» Dominique DE MUIZON (Chauny) Vagues 1+2 Workshop 2 : Is Hep C treatment an harm reduction tool? Presentation of SOS Hepatitis national survey Moderation : Pascal MELIN (Saint Dizier) Round table : Hélène DELAQUAIZE (Paris), Frédéric CHAFFRAIX (Strasbourg), Nathalie KRAICHETTE (Charleville-Mézières) Rhune 2 Workshop 3 : Is what we see when we look at drug users true to their reality? Philippe CHOSSEGROS (Lyon), Agnès CADET TAIROU (Paris), Jean-Pierre COUTERON (Paris), Fiorant DI NINO (Strasbourg), Fabrice OLIVET (Paris) 05.00-07.00 pm : Auditorium - en traduction simultanée Panel/Debate Is war on drugs a failure? What are the alternatives? ANIMATION : Christophe HONDELATTE (Paris) With : Milton ROMANI GERNER / Elena LAGOMARSINO, Junta Nacional de Drogas, Presidencia de la Republica, Montevideo Thomas KERR, PhD, Director, Urban Health Research Initiative, British Columbia Centre for Excellence in HIV/AIDS, University of British Columbia, Vancouver Robert BOOTH, PhD, Clinical Professor of Psychiatry, Denver Javier SAGREDO, Advisor, Democratic Governance and Citizen Security, Regional Bureau for Latin America and the Caribbean, United Nation Development Programme, New York Juan DEL POZO, Coordinador General de la Cooperacion Española en el Uruguay, Agencia Española de Cooperacion International para el Desarrollo (AECID), Montevideo Patrick AEBERHARD, former President and creator of Doctors of the World, co-creator of IHRA, former Counselor at the Ministry of Health 08.00 pm : Meeting Dinner, Plaza Berri 42 Avenue du Maréchal Foch, 64200 Biarritz

Friday october 1 st 2015 09.00-10.30 am : Auditorium - simultaneously translated Community research Chair : Perrine ROUX (Marseille) Engaging People who use Drugs in Research : Experiences from the Urban Health Research Initiative Thomas KERR (Vancouver) Research with community actors : the AERLI example / Perrine ROUX (Marseille) Ipergay and Slam : results and perspectives of 2 community research / Daniela ROJAS CASTRO (Paris) 10.30-10.45 am : break 10.45 am - 01.00 pm : Auditorium - simultaneously translated Drug policies Co-chair : Joan COLOM (Barcelone), Thomas KERR (Vancouver) Meta addictology : from street to recovery / Jacques BESSON (Lausanne) Evolution of the french harm reduction model / Marie JAUFFRET ROUSTIDE (Paris) Evolution of the danish harm reduction model / Esben HOUBORG (Copenhague) Drug policies and human rights / Javier SAGREDO (New York) Role of international cooperation in the approach and development of drug policies / Juan DEL POZO (Montevideo) 01.00-02.30 pm : lunch break, poster session ATHS 2013 With the support of :

Friday october 1 st 2015 / following Auditorium - simultaneously translated Substance use disorders, HIV, HCV, in resource limited countries : the case of Vietnam Co-chair : Gilles RAGUIN (Paris), Don DES JARLAIS (New York), Le Minh GIANG (Hanoi) Moderation : Didier LAUREILLARD (Paris) Substance use disorders in Vietnam since «Doi Moi» (Renovation) : an epidemiologiocal overview and update on national program Le Minh GIANG (Hanoi) Community supported respondent driven sampling among PWID in Hai Phong : a case study with implications for intervention Don DES JARLAIS (New York) Results DRIVE-IN follow-up in Hai-Phong Nicolas NAGOT (Montpellier) Results and follow up of the Integrated treatment for opiate addiction and HIV in HCMC David METZGER (Philadelphie) Rhune 1 - simultaneously translated Tobacco and dual diagnosis (Société Française de Tabacologie) Moderation : Didier TOUZEAU (Paris) Tobacco and suicidal behaviours Ivan BERLIN (Paris) Tobacco and anxiety Mélina FATSEAS (Bordeaux) Tobacco care in psychiatric clinic : an update Nathalie WIRTH (Paris) Tobacco consulting for patients and workers of psychiatric hospital Didier TOUZEAU (Paris) 02.30-04.30 pm : Rhune 2 Workshop 1 : Role of hospital addiction mobile team : screening, orientation and link in and around the hospital Chair : Pierre POLOMENI (Paris) Moderation : Gérard CAMPAGNE (Bayonne) Addiction mobile hospital team : reconciling E Health and mobility. Test and perspectives in Dordogne Anivel RAMOS (Périgueux) Screening and patients orientation of adult and children patients in a mother and child hospital in Paris Emmanuelle PEYRET (Paris) Place of addiction mobile hospital teams in the Pyrénées Orientales area Bénédicte DELMAS (Perpignan) 04.30-05.30 pm : Closing Session Vagues 1+2 Workshop 2 : prevention of risky behaviors : action at all ages Moderation : Nicolas BONNET (Paris) Unplugged, an efficient prevention program in the Nord 92 Laëtitia USUBELLI (Clichy) Motivationnal interviewing with young adults : a pilot program in Rhone Alpes region Anne Cécile CORNIBERT (Paris) Representative students, guide of party nights and «le Plan B» web site : prevention by and for students Anne-Cécile RAHIS (Bordeaux) Vagues 3+4 Workshop 3 : Harm reduction and precariousness Presentation of the movie «RDR 2» from Philippe Lachambre and Laurent Appel, (51 mn) Followed by a discussion : Reducing harms or reducing social divide? Moderation : Fabrice OLIVET (Paris) Céline OYHENARD (Gagny), Valère ROGISSART (Paris)